SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-163395
Filing Date
2024-06-18
Accepted
2024-06-18 16:06:02
Documents
14
Period of Report
2024-06-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d614069d8k.htm   iXBRL 8-K 38887
2 EX-3.1 d614069dex31.htm EX-3.1 33642
  Complete submission text file 0001193125-24-163395.txt   209642

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lyra-20240613.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20240613_lab.xml EX-101.LAB 18723
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20240613_pre.xml EX-101.PRE 11714
17 EXTRACTED XBRL INSTANCE DOCUMENT d614069d8k_htm.xml XML 3833
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 241051720
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)